Bringing Together Innovators, Leading Investors and Major Healthcare Corporations

The 27th MedTech Investing Europe Conference will be held on April 2019 in Lausanne, Switzerland. We will be welcoming over 130 attendees and showcasing an unrivalled roster of venture-stage life science companies.

Our programme will include a mix of leading investors and healthcare industry specialists with a range of topical debates, from a look at how healthcare economics plays out in the real world to a 360 look at exits.

Our investor community includes single family office and private multi-family offices worth at least €100 million as well as some of the most pro-active VC, angel and corporate investors. Financiers will be attending from 4 continents and represent some of the most active and innovative investors in the sector.

MTI speakers represent some of the most successful investors, entrepreneurs and life science specialists in the sector. Chosen for their knowledge, insight and first-hand experience they will give our audience the tools they need to develop winning investment strategies, successful commercialisation plans and accurately plan for the future.

To enquire about speaking opportunities at April's Lausanne, please contact Peter Newton, peternewton@campdenwealth.com or +44(0)203 763 2800.

Over the last 25 events we have showcased over 870 early- to mid-stage life science companies to our unrivalled audience of investors. Representing all areas of life sciences our presenting companies originate from over 37 countries and are at a range of different stages from pre-clinical to commercialisation. Just some of the previous companies include:

A full list of current presenting companies will be made available as soon as you register for the event in Lausanne.

Programme

The MTI conference programmes address the biggest topics in the industry today, from investment topics such as “Where is the money coming from?” and “What do family offices look for and how do they invest?” to wider challenges such as “How does healthcare economics playout in the real world?” and “How do you plan and execute a successful exit”.

The conference programmes are developed in conjunction with the MTI Investor Advisory Board – a collection of the biggest investors in the sector with assets under management of over €40bn.

Our speaking faculty represent the truly global nature of the life sciences industry with panellists drawn from leading organisations from Europe, North America and Asia.